文献速递瘢痕与激光

人瘢痕疙瘩中与上皮-间质转化相关的生物标志物

The biomarkers associated with epithelial-mesenchymal transition in human keloids.
PubMed 文献 · Burns · 2023-09-26

研究利用GSE92566数据集(3例正常皮肤与4例瘢痕疙瘩组织)识别122个上皮-间质转化相关差异表达基因,通过富集分析、蛋白互作网络和miRNA-mRNA网络分析筛选出10个枢纽基因,预测利巴韦林具有高药物靶向相关性,并用qRT-PCR和体外实验验证了部分基因表达及利巴韦林抑制人瘢痕疙瘩成纤维细胞增殖和上皮-间质转化的作用。

要点

  • 共识别122个上皮-间质转化相关差异表达基因,含59个上调、63个下调基因。
  • 10个枢纽基因为FN1、EGF、SOX9、CDH2、PROM1、EPCAM、KRT19、ITGB1、CD24、KRT18。
  • qRT-PCR证实FN1、ITGB1、CDH2、EPCAM表达与前期发现一致,hsa-miR-124-3p和hsa-miR-145-5p在瘢痕疙瘩中显著降低,hsa-miR-155-5p上调。

核心结论

  • 本研究提供了瘢痕疙瘩中新的上皮-间质转化生物标志物,并预测了用于瘢痕疙瘩治疗的新小分子靶点,增进了对瘢痕疙瘩发病机制的理解并提供新的治疗选择。

研究设计与样本

  • 从GEO数据库下载GSE92566数据集(3例正常皮肤与4例瘢痕疙瘩组织)识别差异表达基因,从dbEMT 2.0数据库下载上皮-间质转化相关基因并与GSE92566差异表达基因取交集识别上皮-间质转化相关差异表达基因。
  • 对上皮-间质转化相关差异表达基因进行GO、KEGG、基因集富集分析、蛋白-蛋白互作和miRNA-mRNA网络分析,并将基因导入cMAP和DGidb数据库预测小分子和药物靶向关系。
  • 通过qRT-PCR和体外实验验证findings。

主要发现

  • 共识别122个上皮-间质转化相关差异表达基因,包括59个上调基因和63个下调基因。
  • 富集分析显示粘着斑、AMPK信号通路、Wnt信号通路和上皮-间质转化生物学过程显著富集。
  • 从蛋白-蛋白互作网络中探索出3个模块和10个枢纽基因(FN1、EGF、SOX9、CDH2、PROM1、EPCAM、KRT19、ITGB1、CD24、KRT18),这些基因富集于粘着斑通路。
  • 构建的miRNA-mRNA网络中,预测hsa-miR-155-5p(8条边)、hsa-miR-124-3p(7条边)、hsa-miR-145-5p(5条边)、hsa-miR-20a-5p(5条边)和hsa-let-7b-5p(4条边)为调控上皮-间质转化连接最多的miRNA。
  • qRT-PCR证实FN1、ITGB1、CDH2和EPCAM的表达与前期发现一致;qRT-PCR显示hsa-miR-124-3p和hsa-miR-145-5p在瘢痕疙瘩中表达水平显著降低,hsa-miR-155-5p在瘢痕疙瘩中上调。

关键数值与推荐

  • 基于上皮-间质转化相关差异表达基因和上述10个枢纽基因,利巴韦林显示出高药物靶向相关性。

临床怎么用

  • 作者认为本研究增进了对瘢痕疙瘩发病机制的理解,并提供了新的治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A keloid is a type of benign fibrotic disease with similar features to malignancies, including anti-apoptosis, over-proliferation, and invasion. Epithelial-mesenchymal transition (EMT) is a crucial mechanism that regulates the metastatic behavior of tumors. Thus, identifying EMT biomarkers is paramount in comprehensively understanding keloid pathogenesis. METHODS: To identify the differentially expressed genes (DEGs) GSE92566 dataset, with 3 normal skin and 4 keloid tissues, was downloaded from GEO databases to identify the differentially expressed genes (DEGs). Further, EMT-related genes were downloaded from dbEMT 2.0 databases and intersected with GSE92566 DEGs to identify EMT-related-DEGs (ERDEGs). Subsequently, the ERDEGs were used for GO, KEGG, gene set enrichment analysis (GSEA), protein-protein interaction (PPI), and miRNAs-mRNAs network analysis. To predict small molecules for EMT inhibition, the ERDEGs were imported to cMAP databases, whereas hub genes were imported to DGidb databases. Finally, we carried out qRT-PCR and in vitro experiments to validate our findings. RESULTS: A total of 122 ERDEGs were identified, including 59 upregulated and 63 down-regulated genes. Moreover, enrichment analysis revealed that focal adhesion, AMPK signal pathway, Wnt signal pathway, and EMT biological process were significantly enriched. STRING databases and Cytoscape software were used to construct the PPI network and EMT-related hub genes. Further, 3 modules were explored from the PPI network using the Molecular Complex Detection (MCODE) plugin. In the Cytohubba plugin, 10 hub genes were explored, including FN1, EGF, SOX9, CDH2, PROM1, EPCAM, KRT19, ITGB1, CD24, and KRT18. These genes were then enriched for the focal adhesion pathway. We constructed a microRNA (miRNA)-mRNA network, which predicted hsa-miR-155-5p (8 edges), hsa-miR-124-3p (7 edges), hsa-miR-145-5p (5 edges), hsa-miR-20a-5p (5 edges) and hsa-let-7b-5p (4 edges) as the most connected miRNAs regulating EMT. Based on the ERDEGs and 10 hub genes mentioned above, ribavirin demonstrated high drug-targeting relevance. Subsequently, qRT-PCR confirmed that the expression of FN1, ITGB1, CDH2, and EPCAM corroborated with previous findings. qRT-PCR also showed that the expression levels of hsa-miR-124-3p and hsa-miR-145-5p were significantly lower in keloids and hsa-miR-155-5p was upregulated in keloids. Finally, by treating human keloid fibroblasts (HKFs) with ribavirin in vitro, we confirmed that ribavirin could inhibit HKFs proliferation and EMT. CONCLUSION: In summary, this work provides novel EMT biomarkers in keloids and predicts new small target molecules for keloid therapy. Our findings improve the understanding of keloid pathogenesis, providing new treatment options.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Qiu ZK, Yang E, Yu NZ, et al. The biomarkers associated with epithelial-mesenchymal transition in human keloids. Burns. 2023. PMID: 37980270. doi:10.1016/j.burns.2023.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。